Yayın:
Observational study of immunosuppressive treatment patterns and outcomes in primary membranous nephropathy: A multicenter retrospective analysis

Küçük Resim

Akademik Birimler

Yazarlar

Artan, Ayse Serra
Mirioglu, Safak
Hocaoglu, Rabia Hacer
Turgutalp, Kenan
Boz, Saide Elif Gullulu
Eren, Necmi
Dincer, Mevlut Tamer
Uzun, Sami
Sahin, Gulizar
Kutlay, Sim

Danışman

Dil

Türü

Yayıncı:

BMC

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Özet

Background We evaluated the efficacy of different immunosuppressive regimens in patients with primary membranous nephropathy in a large national cohort. Methods In this registry study, 558 patients from 47 centers who were treated with at least one immunosuppressive agent and had adequate follow-up data were included. Primary outcome was defined as complete (CR) or partial remission (PR). Secondary composite outcome was at least a 50% reduction in estimated glomerular filtration (eGFR), initiation of kidney replacement therapies, development of stage 5 chronic kidney disease, or death. Results Median age at diagnosis was 48 (IQR: 37-57) years, and 358 (64.2%) were male. Patients were followed for a median of 24 (IQR: 12-60) months. Calcineurin inhibitors (CNIs) with or without glucocorticoids were the most commonly used regimen (43.4%), followed by glucocorticoids and cyclophosphamide (GC-CYC) (39.6%), glucocorticoid monotherapy (25.8%), and rituximab (RTX) (9.1%). Overall remission rate was 66.1% (CR 26.7%, PR 39.4%), and 59 (10.6%) patients reached secondary composite outcome. Multivariate logistic regression showed that baseline eGFR (OR 1.011, 95% CI: 1.003-1.019, p = 0.007), serum albumin (OR 1.682, 95% CI: 1.269-2.231, p < 0.001), and use of RTX (OR 0.296, 95% CI: 0.157-0.557, p < 0.001) were associated with remission rates; whereas only lower baseline hemoglobin was significantly associated with secondary composite outcome (OR: 0.843, 95% CI: 0.715-0.993, p = 0.041). CYC use was significantly associated with higher remission (OR 1.534, 95% CI: 1.027-2.290, p = 0.036). Conclusions Higher baseline eGFR and serum albumin levels correlated with increased remission rates. Remission rates were lower in patients treated with RTX, while those on GC-CYC showed higher rates of remission. Due to the study's retrospective nature and multiple treatments used, caution is warranted in interpreting these findings.

Açıklama

Kaynak:

Anahtar Kelimeler:

Konusu

Follow-up, Methylprednisolone, Cyclophosphamide, Chlorambucil, Rituximab, Trial, Cyclosporine, Tacrolimus, Steroids, Receptor, Membranous nephropathy, Immunosuppression, Chronic kidney disease, Remission, Science & technology, Life sciences & biomedicine, Urology & nephrology

Alıntı

Endorsement

Review

Supplemented By

Referenced By

2

Views

13

Downloads

View PlumX Details